摘要
目的:观察中西医结合治疗慢阻肺急性加重期的临床疗效。方法:选取50例慢阻肺急性加重期患者,随机分为对照组和观察组,各25例。对照组给予噻托溴铵治疗,观察组在对照组基础上给予有麻汤治疗。比较两组治疗前后肺功能指标FEV1、FVC、FEV1/FVC水平以及治疗效果。结果:治疗后观察组FEV1、FVC、FEV1/FVC分别为(1.87±0.23)L、(2.57±0.53)L、(74.27±6.35)%,均高于对照组的(1.25±0.12)L、(2.04±0.43)L、(68.43±6.53)%,差异有统计学意义(P<0.05)。观察组总有效率96.00%,高于对照组的76.00%,差异有统计学意义(P<0.05)。结论:对于慢阻肺急性加重期的患者实施中西医结合治疗可有效提高临床疗效,值得在临床中推广应用。
Objective Analysis of the clinical efficacy of integrated traditional Chinese and western medicine in the treatment of acute exacerbation of COPD.Methods Fifty patients with COPD were randomly divided into a control group and an observation group,25 cases each.The control group was given Tiotropium bromide treatment,and the observation group was given Youma Decoction based on the control group.The treatment effects of the two groups and the levels of lung function indexes FEV1,FVC,FEV1/FVC before and after treatment were compared.Results The total treatment rate of patients in the observation group was 96.00%,higher than that in the control group(76.00%),(P<0.05).After treatment,the FEV1,FVC,and FEV1/FVC of the observation group were(1.87±0.23)L,(2.57±0.53)L,(74.27±6.35)%,which were higher than that of the control group(1.25±0.12)L,(2.04±0.43)L,(68.43±6.53)%,(P<0.05).Conclusion For patients with acute exacerbation of COPD,the combination of traditional Chinese and Western medicine can effectively improve the clinical efficacy,and it is worthy of popularization and application in clinical.
作者
孙贺
石绍顺
SUN He;SHI Shaoshun(Liaoning University of Traditional Chinese Medicine,Shenyang 110847,China;Department of Intensive Medicine,Second Affiliated Hospital of Liaoning University of Traditional Chinese Medicine,Shenyang 110034,China)
出处
《中国民族民间医药》
2021年第4期94-96,共3页
Chinese Journal of Ethnomedicine and Ethnopharmacy
关键词
中西医结合
慢性阻塞性肺疾病
急性加重期
疗效
Integrated Chinese and Western Medicine
Chronic Obstructive Pulmonary Disease
Acute Exacerbation Period
Efficacy
